profit from every $100 of sales.
$0$100
Veeva Systems
$305.55-0.28% today
+3.3% in 1 year
1-year low $151.431-year high $323.04
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2026.
0%20% a year
You pay $54.43 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Veeva Systems sold, what it kept, and what it did with the cash.
Sales went from $2.16 billion in 2023 to $3.20 billion in 2026, with $909 million of profit last year.
SalesProfit
Veeva Systems handed back 12% of the cash it generated last year.
Buybacks $170M
Free cash flow 2026$1.4B
Bought back its own shares$170M
Paid as dividends–
Cash vs. debt$1.4B vs. $96M
Veeva Systems vs. similar companies
Veeva Systems grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Veeva Systems | 54.4× · Expensive | ||
 Pro Medicus | 186.7× · Very expensive | ||
 Hinge Health | No profit yet | ||
 M3 | 31.0× · Expensive | ||
 Waystar | 50.3× · Expensive |
AI analysis
An AI analyst reads Veeva Systems's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| 1,465 | 1,851 | 2,155 | 2,364 | 2,747 | 3,195 | |
| 1,056 | 1,347 | 1,546 | 1,686 | 2,047 | 2,413 | |
| 378 | 505 | 459 | 429 | 691 | 916 | |
| – | – | 488 | 462 | 731 | 954 | |
| 380 | 427 | 488 | 526 | 714 | 909 | |
| 2.36 | 2.63 | 3.00 | 3.22 | 4.32 | 5.44 | |
| 72.1% | 72.8% | 71.7% | 71.3% | 74.5% | 75.5% | |
| 25.8% | 27.3% | 21.3% | 18.2% | 25.2% | 28.7% | |
| 25.9% | 23.1% | 22.6% | 22.2% | 26.0% | 28.4% |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Total assets | 3,046 | 3,816 | 4,804 | 5,911 | 7,340 | 8,979 |
| Cash | 731 | 1,138 | 886 | 703 | 1,119 | 1,421 |
| Total debt | – | – | 61 | 56 | 76 | 96 |
| Total liabilities | 780 | 905 | 1,088 | 1,266 | 1,507 | 1,765 |
| 2,266 | 2,912 | 3,716 | 4,645 | 5,832 | 7,215 | |
| 161 | 162 | 162 | 163 | 165 | 167 | |
| 13.2% | 13.7% | 9.6% | 7.2% | 9.2% | 9.9% | |
| 16.8% | 14.7% | 13.1% | 11.3% | 12.2% | 12.6% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| 551 | 764 | 780 | 911 | 1,090 | 1,415 | |
| – | – | – | – | – | – | |
| – | – | 780 | 911 | 1,090 | 1,415 | |
| Dividends paid | – | – | – | – | – | – |
| – | – | – | 0 | 0 | 170 | |
| 185 | 235 | 352 | 394 | 437 | 473 |
Valuation
- 54.4×
- 34.5×
- 2.99
- 6.8×
- 15.5×
- 35.0×
- 50.4×
- 2.9%
- 1.8%
- 0.0%
Profitability
- 75.5%
- 28.7%
- 28.4%
- 30.1%
- 10.2%
- 9.2%
- 13.4%
- 10.3%
- 12.9%
- 23.9%
Growth
- +16.9%
- +18.2%
- +29.6%
- –
- +0.9%
Financial health
- -1.4×
- 0.01
- 1.1%
- –
- 4.89
- 4.74
- 0.36
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 28%of 953
Top 11%of 877
Bottom 21%of 564
Top 34%of 871
Top 35%of 988
What analysts expect
- Average price target
- $280.10
- Range
- $205.00 – $333.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 4, 2026 | 2.06 | 1.94 | +6.2% |
| Nov 20, 2025 | 2.04 | 1.95 | +4.6% |
| Aug 27, 2025 | 1.99 | 1.90 | +4.7% |
| Mar 5, 2025 | 1.74 | 1.60 | +8.7% |
| Dec 5, 2024 | 1.75 | 1.58 | +10.8% |
| Aug 28, 2024 | 1.62 | 1.53 | +5.9% |
| May 30, 2024 | 1.50 | 1.42 | +5.6% |
| Feb 29, 2024 | 1.38 | 1.30 | +6.2% |
News
Guidance Up, Trend Intact: Veeva Is Today's Double-Confirmation StockYahoo Finance · Oct 23, 2026Is Veeva Systems Stock Really Expensive?Yahoo Finance · Oct 21, 2026Reasons to Hold Veeva Systems Stock in Your Portfolio for NowYahoo Finance · Sep 3, 2026Notable healthcare headlines for the week: Veeva Systems, Boston Scientific in focusSeeking Alpha · Aug 30, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
63Pass
Benjamin Graham
50No pass
Philip Fisher
71Pass
Peter Lynch
52No pass
Joel Greenblatt
11No pass
Charlie Munger
62Pass
Terry Smith
64Pass
Questions about Veeva Systems
Is Veeva Systems a good stock to buy?
A strong, very profitable business, but the price is high. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Veeva Systems AI analysis
What does Veeva Systems do?
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. It is in Health Information Services, based in Pleasanton, CA, United States, with 7,928 employees.
Does Veeva Systems pay a dividend?
No. Veeva Systems does not pay a dividend at the moment; in 2026 it returned $170 million to shareholders by buying back its own shares.
Is Veeva Systems stock halal?
No. Veeva Systems does not pass our halal screen: interest on its cash and investments is about 8.4% of its revenue. How we check
How has Veeva Systems stock done over the past year?
Up 3.3% over the past twelve months, to $305.55. It traded between $151.43 and $323.04 and is 5.4% below its high.
Who are Veeva Systems's competitors?
The largest listed companies in the same industry are Pro Medicus, Hinge Health, M3 and Waystar. The peers table on this page compares their profit, growth and price with Veeva Systems's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.